Home Search

ugro - search results

If you're not happy with the results, please do another search

urban-gro (UGRO) We Have Another Double!

Last May we asked, "Is Urban-Gro the Most Undervalued Cannabis Play in the Market?" Looks like it was, having doubled less than...
Marijuana Stock Review, urban-gro

urban-gro (UGRO) $10.15 Marijuana’s First Fully Integrated Indoor Cultivation Powerhouse.

urban-gro announces its first major acquisition since raising $62 million in February and it's a doozey! The inclusion of architecture allows them...
urban-gro

Is urban-gro (UGRO) $7.50, the Most Undervalued Cannabis Play in the Market?

Listen to Today's Conference Call at 5:00 PM EST to Find Out for Yourself. What the, look at...
Brad Natrass, Marijuana Stock Review

Urban Gro (UGRO) $8.00 Conference Call 8:30 This Morning.

urban-gro, Inc. to Report Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call – Company to...

Adding Vext Science (VEXTF) $0.17 to the Watch List.

Quite Simply, We've Found the Best Run Marijuana Grower, and it's Profitable to Boot! Based in Arizona, Our...

ThinkEquity Investor Conference (NYC), Wednesday October 26th.

ThinkEquity is a boutique investment bank run by experienced professionals that have worked together for over a...

Adding Smart for Life (SMFL) $0.85 to the Watch List.

Adding another "Broken" IPO to the Watch List. We're not sure if "broken" is the appropriate description, when...

Seven of the World’s Top Performing Stocks, Every Week.

THE TIKI HUT FUND | LAST 7 DAYS BIGGEST MOVERS
Internet Stock Review

Stocks On The Move!

Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...

Tiki Hut Fund. The Past Year’s Biggest Losers!

The Past Year's Biggest Losers! Here's an interesting look at the biggest losers...

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...